Kai-Keen Shiu: Love all the data on neoadjuvant IO at ASCO24!
Kai-Keen Shiu, a Medical Oncology Consultant for the Gastrointestinal Oncology Service at University College London Hospitals NHS Foundation Trust recently shared a post by Myriam Chalabi on X, adding:
“Thank you Myriam Chalabi for taking a better ASCO24 selfie than me! Many congratulations to you + your team NICHE2 in NEJM.
I have kept these pictures from ESMO 2022 for a timely post. Thank you for the chats we have had since over. Onwards to ESMO GI.”
Quoting Myriam Chalabi‘s post:
“Kai-Keen Shiu ready for neoprism presentation! Love all the data on neoadjuvant IO at ASCO24!”
Sources: Kai-Keen Shiu/X and Myriam Chalabi/X
Dr. Myriam Chalabi, a medical oncologist and researcher based at the Netherlands Cancer Institute, specializes in gastrointestinal tract cancer. Her research primarily focuses on immunotherapy for gastrointestinal cancers.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023